Lundbeck Foundation doubles investment in biotech company
![Foto: Colourbox](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article6515409.ece/ALTERNATES/schema-16_9/Seed%2520Funding1.jpg)
The Lundbeck Foundation has injected an additional DKK 15 million into the Aarhus-based biotech company Insusense Therapeutics. The foundation thus doubles its investment in the company, which develops novel drugs to treat type 2 diabetes and obesity, the Lundbeck Foundation says in a press release sent to MedWatch.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
More Nordic investor syndicates could be on the way
For abonnenter
Lene Skole: Most opportunities arise outside of Denmark
For abonnenter